• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1500400-38
Device Problems Difficult to Remove (1528); Material Rupture (1546); Difficult or Delayed Activation (2577); Patient-Device Incompatibility (2682)
Patient Problems Arrhythmia (1721); Bradycardia (1751); Cardiac Arrest (1762); Myocardial Infarction (1969); Occlusion (1984); Respiratory Failure (2484)
Event Date 07/31/2020
Event Type  Injury  
Manufacturer Narrative
The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.User facility medwatch report number (b)(4).
 
Event Description
User facility medwatch report received that states: "stent delivery balloon ruptured during inflation after approx 6-8 atmospheres of pressure; (b)(6) 2020 procedure - the intervention was complicated by technical malfunction of the 4.0 x 38 mm xience stent in the mid right coronary artery.The stent delivery balloon ruptured during inflation after approximately 6 to 8 atmospheres of pressure.This resulted in incomplete expansion of the stent.We were unable to remove the stent delivery balloon or get the device out through the guide catheter.Ultimately, it was further partially and asymmetrically deployed, as detailed below, using the ruptured balloon.With this complication, the patient developed bradycardiac cardia arrest, essentially with the transient asystole and subsequent severe bradycardia.Ultimately, she would require iv vasopressor and inotropic therapy, as wall as emergent intubation for airway support.Intubation was provided by the emergency room physician and subsequent airway management and vasopressor therapy guided by the critical care staff.With this complication, we also lost flow through the right coronary artery.Ultimately we were able to restore flow through the artery, but the patient did suffer an infraction as a result.".
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record and complaint history of the reported lot could not be conducted because the lot number was not provided.The reported patient effects arrhythmia, occlusion, and myocardial infarction are listed in the xience sierra everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.The investigation was unable to determine a conclusive cause for the reported material rupture; however, factors that may contribute to material ruptures include, but are not limited to, material damage, interactions with other devices or interaction with lesion calcification and tortuosity.Removal of the delivery catheter was difficult as the device met resistance with the guiding catheter due to the ruptured balloon.The stent was ultimately implanted using the ruptured balloon; however, the reported delayed activation and subsequent issue with wall apposition were experienced.The reported patient effects and treatment appear to be related to operational context of the procedure.It should be noted that the device was not returned for analysis and although multiple attempts were made to attain further information, no information was provided.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10730173
MDR Text Key213009556
Report Number2024168-2020-08876
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type user facility
Type of Report Initial,Followup
Report Date 11/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/23/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1500400-38
Was Device Available for Evaluation? No
Date Manufacturer Received11/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
-
-